Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment

Approximately 90 % of patients who die of prostate cancer (PCa) have bone metastases, often promoting osteoblastic lesions. We observed that 88 % of castration-resistant PCa (CRPC) bone metastases express prostatic acid phosphatase (PAP), a soluble secreted protein expressed by prostate epithelial c...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Larson, Sandy R., Chin, Jessica, Zhang, Xiaotun, Brown, Lisha G., Coleman, Ilsa M., Lakely, Bryce, Tenniswood, Martin, Corey, Eva, Nelson, Peter S., Vessella, Robert L., Morrissey, Colm
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3946934/
https://ncbi.nlm.nih.gov/pubmed/24242705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10585-013-9625-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak